AtCor Medical Holdings (ACG)

Stock Code

ACG

Stock Exchange

Australian Securities Exchange

AtCor Medical Holdings (ACG) designs, manufactures and markets medical devices intended for cardiovascular management. The Company makes products for clinical settings that are used in non-invasive cardiovascular evaluation and patient management. ACG is headquartered in Sydney. AtCor sells its products via a network of national distributors located in many countries across the world, with the help of its American subsidiary AtCor Medical Inc (USA) based in Chicago, IL and through a representative office in Europe. ACG was listed on the Australian on Stock Exchange 9 November, 2005. SphygmoCor system is a key product of AtCor, which is used to measure central blood pressures non-invasively at the heart. The SphygmoCor Px system is another product of the Company that balances the traditional cuff sphygmomanometer by non-invasively offering certain previously unavailable central clinical information.

AtCor Medical's operations are spread across three geographical regions: North America, Europe (comprises Middle East and North Africa) and rest of world (comprises Asia, Australia/NZ and South America). AtCor Medical has collaborations with researchers in Australia, Europe and the USA for the development of the clinical applications and the improvement of the capabilities of its non-invasive cardiovascular products. The Company intends to work with researchers and clinicians in order to make new products, and enhance its existing products, in the medical market.

AtCor Medical Holdings History

AtCor Medical was established in 1994. It listed on the Australian Stock Exchange on 9th November, 2005.